Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Krag

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Biopolymers|June 22, 2010
Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domainNigus D Ambaye, Reece C C Lim, Daniel J Clayton, et al.
Journal of Surgical Oncology|July 22, 2010
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissectionTakamaru Ashikaga, David N Krag, Stephanie R Land, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2025
Cancer therapy via neoepitope-specific monoclonal antibody cocktailsColin J Hartman, Asmaa O Mohamed, Girja S Shukla, et al.
Annals of Surgical Oncology|May 8, 2003
Lymphoscintigraphy and sentinel node biopsy accurately stage melanoma in patients presenting after wide local excisionHeather L Evans, David N Krag, C David Teates, et al.
Journal of Translational Medicine|October 4, 2013
Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patientsAndrew Y Chang, Nupur Bhattacharya, Jian Mu, et al.
Journal of Molecular Biology|August 2, 2011
Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progressionNigus D Ambaye, Stephanie C Pero, Menachem J Gunzburg, et al.
The Lancet. Oncology|September 25, 2010
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialDavid N Krag, Stewart J Anderson, Thomas B Julian, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2018
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph nodeJonathan R McDaniel, Stephanie C Pero, William N Voss, et al.
The Lancet. Oncology|September 14, 2007
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialDavid N Krag, Stewart J Anderson, Thomas B Julian, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Biopolymers|June 22, 2010
Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domainNigus D Ambaye, Reece C C Lim, Daniel J Clayton, et al.
Journal of Surgical Oncology|July 22, 2010
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissectionTakamaru Ashikaga, David N Krag, Stephanie R Land, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2025
Cancer therapy via neoepitope-specific monoclonal antibody cocktailsColin J Hartman, Asmaa O Mohamed, Girja S Shukla, et al.
Annals of Surgical Oncology|May 8, 2003
Lymphoscintigraphy and sentinel node biopsy accurately stage melanoma in patients presenting after wide local excisionHeather L Evans, David N Krag, C David Teates, et al.
Journal of Translational Medicine|October 4, 2013
Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patientsAndrew Y Chang, Nupur Bhattacharya, Jian Mu, et al.
Journal of Molecular Biology|August 2, 2011
Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progressionNigus D Ambaye, Stephanie C Pero, Menachem J Gunzburg, et al.
The Lancet. Oncology|September 25, 2010
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialDavid N Krag, Stewart J Anderson, Thomas B Julian, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2018
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph nodeJonathan R McDaniel, Stephanie C Pero, William N Voss, et al.
The Lancet. Oncology|September 14, 2007
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialDavid N Krag, Stewart J Anderson, Thomas B Julian, et al.
Pageof 7